SCHEMBL16236256

SCHEMBL16236256

CCOC(=O)Oc1cccc2cccc(SC(=O)N(CC)CC)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
TYMS P04818 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 4/20 0.37
TP53 P04637 1/20 0.37
HTT P42858 1/20 0.37
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAOB P27338 1/20 0.33
ELANE P08246 1/20 0.33
BCHE P06276 1/20 0.33
CDC25B P30305 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236033 0.86 HSD17B10 (0.52) HSD17B10ALDH1A1HPGDTSHRNPC1
SCHEMBL16239303 0.85 TYMS (0.41) HSD17B10ALDH1A1HPGDTYMSKDM4E
SCHEMBL16236142 0.82 ALDH1A1 (0.53) HSD17B10ALDH1A1HPGDTSHRKDM4E
SCHEMBL16239219 0.82 HSD17B10 (0.48) HSD17B10ALDH1A1HPGDTSHRKDM4E
SCHEMBL16235879 0.81 ALDH1A1 (0.64) HSD17B10ALDH1A1HPGDTSHRKDM4E
SCHEMBL16235702 0.81 LMNA (0.43) HSD17B10ALDH1A1HPGDTSHRKDM4E
SCHEMBL16236443 0.81 NPC1 (0.40) HSD17B10ALDH1A1HPGDTYMSKDM4E
SCHEMBL16235755 0.80 ALDH1A1 (0.46) HSD17B10ALDH1A1HPGDTSHRKDM4E
SCHEMBL1958548 0.80 TYMS (0.49) HSD17B10ALDH1A1HPGDTYMSTSHR
SCHEMBL16236375 0.78 ALDH1A1 (0.45) HSD17B10ALDH1A1HPGDTSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005860-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-06-26 US disclosed
EP-2997049-B1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA SRL (IT) 2017-08-23 EP disclosed
US-20170166667-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-06-15 US disclosed
US-9644051-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-05-09 US disclosed
US-20160090428-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia, s.r.l. (IT) 2016-03-31 US disclosed
EP-2997049-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2016-03-23 EP disclosed
WO-2014184289-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2014-11-20 WO disclosed
EP-2803679-A1 Catalyst components for the polymerization of olefins Basell Poliolefine Italia S.r.l. (IT) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005860-B2 Catalyst components for the polymerization of olefins OXER1, OXSR1, NR0B2 HSD17B10 1221/4885ALDH1A1 2092/4885HPGD 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.